Macquarie Group’s ResMed RMD Stock Holding History

Macquarie Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,200	Closed	-$230K	–	1541
2017 Q1	$230K	Buy	+3,200	New	+$221K	﹤0.01%	1412
2016 Q4	–	Sell	-5,000	Closed	-$324K	–	1572
2016 Q3	$324K	Buy	+5,000	New	+$333K	﹤0.01%	1360
2015 Q3	–	Sell	-400	Closed	-$23K	–	1639
2015 Q2	$23K	Buy	+400	New	+$25.2K	﹤0.01%	1585
2014 Q4	–	Sell	-1,085,207	Closed	-$53.5M	–	1608
2014 Q3	$53.5M	Buy	+1,085,207	New	+$55.3M	0.11%	167
2014 Q1	–	Sell	-8,190	Closed	-$386K	–	1580
2013 Q4	$386K	Buy	8,190 +4,328	+112%	+$219K	﹤0.01%	1306
2013 Q3	$204K	Buy	+3,862	New	+$187K	﹤0.01%	1414

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group's RMD Position: Q1 2026 in Review

Macquarie Group reduced its ResMed (RMD) stake by 31% in Q1 2026, selling an estimated $10.2M and leaving 89,565 shares worth $20.1M. The position accounts for 0.12% of the portfolio, ranked #152.

Macquarie Group first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $106M in Q3 2014. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Macquarie Group held 89,565 shares of ResMed worth $20.1M as of Q1 2026.
Macquarie Group sold 40,777 ResMed shares in Q1 2026, an estimated $10.2M.
ResMed made up 0.12% of Macquarie Group's portfolio in Q1 2026, its #152 holding.
Macquarie Group first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
Macquarie Group's ResMed position peaked at $106M in Q3 2014.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.